Moderna (MRNA)

Free Cash Flow

-$1.22B

TTM · Period ending: · USD

MRNA logo

MRNA Free Cash Flow

Latest reported-$1.22B
MRNA TTM Free Cash Flow (-$389.89M → -$1.22B)
High-resolution chart · PNG

MRNA free cash flow history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Moderna Free Cash Flow — Trailing twelve months (TTM) (USD)
Period endingFree Cash Flow (USD)
-1,223,000,000
-1,582,000,000
-2,054,000,000
-2,663,000,000
-3,500,000,000
-4,034,000,000
-4,055,000,000
-3,956,000,000
-3,979,000,000
-3,672,000,000
-3,825,000,000
-2,657,000,000
-754,000,000
612,000,000
4,581,000,000
6,201,000,000
9,215,000,000
13,031,000,000
13,336,000,000
11,386,988,000
9,083,444,000
5,007,937,000
1,959,523,000
616,100,000
-371,115,000
-451,414,000
-490,522,000
-492,744,000
-485,336,000
-444,859,000
-436,631,000
-446,861,000
-412,228,000
-431,539,000
-389,885,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.